Sign up
Log in
12 Health Care Stocks Moving In Thursday's After-Market Session
Share
Listen to the news

Gainers

  • Polyrizon (NASDAQ:PLRZ) stock rose 8.5% to $1.15 during Thursday's after-market session. The company's market cap stands at $6.1 million.
  • Prenetics Global (NASDAQ:PRE) stock rose 7.1% to $8.59. The market value of their outstanding shares is at $104.9 million. As per the news, the Q1 earnings report came out today.
  • Adaptimmune Therapeutics (NASDAQ:ADAP) stock moved upwards by 7.07% to $0.26. The company's market cap stands at $69.7 million.
  • Scilex Holding (NASDAQ:SCLX) stock moved upwards by 6.58% to $5.5. The market value of their outstanding shares is at $30.2 million.
  • Nuwellis (NASDAQ:NUWE) shares rose 5.91% to $0.33. The company's market cap stands at $1.4 million.
  • Health Catalyst (NASDAQ:HCAT) stock increased by 5.52% to $4.2. The company's market cap stands at $292.3 million.

Losers

  • Healthcare Triangle (NASDAQ:HCTI) stock fell 16.3% to $0.03 during Thursday's after-market session. The company's market cap stands at $10.2 million.
  • Rein Therapeutics (NASDAQ:RNTX) shares declined by 12.7% to $1.72. The market value of their outstanding shares is at $38.1 million.
  • Liminatus Pharma (NASDAQ:LIMN) shares decreased by 10.79% to $18.12. The company's market cap stands at $471.3 million.
  • bioAffinity Technologies (NASDAQ:BIAF) shares declined by 8.63% to $0.28. The market value of their outstanding shares is at $7.5 million.
  • Compass Pathways (NASDAQ:CMPS) stock decreased by 8.19% to $4.15. The market value of their outstanding shares is at $388.2 million.
  • NuCana (NASDAQ:NCNA) shares decreased by 6.52% to $0.14. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.